Kestra Advisory Services’s Bionano Genomics BNGO Stock Holding History

Kestra Advisory Services’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-174	Closed	-$63.6K	–	2120
2023 Q2	$63.6K	Buy	174 +99	+132%	+$44.7K	﹤0.01%	2033
2023 Q1	$50K	Buy	75 +35	+88%	+$31.1K	﹤0.01%	1993
2022 Q4	$34.7K	Sell	40 -1	-2%	-$1.26K	﹤0.01%	2201
2022 Q3	$45K	Sell	41 -12	-23%	-$15.9K	﹤0.01%	2035
2022 Q2	$44K	Buy	53 +13	+33%	+$13.4K	﹤0.01%	2048
2022 Q1	$61K	Sell	40 -1	-2%	-$1.35K	﹤0.01%	1956
2021 Q4	$74K	Buy	41 +16	+64%	+$42.8K	﹤0.01%	1957
2021 Q3	$83K	Sell	25 -1	-4%	-$3.5K	﹤0.01%	2067
2021 Q2	$116K	Buy	26 +1	+4%	+$3.95K	﹤0.01%	1938
2021 Q1	$122K	Buy	+25	New	+$141K	﹤0.01%	1792

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Kestra Advisory Services's BNGO Position: Q3 2023 in Review

Kestra Advisory Services sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 174 shares — an estimated $63.6K sold.

Kestra Advisory Services first reported a position in BNGO in Q1 2021 and held it in 10 quarters. The position peaked at $122K in Q1 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

Kestra Advisory Services reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
Kestra Advisory Services sold 174 Bionano Genomics shares in Q3 2023, an estimated $63.6K.
Kestra Advisory Services first reported a position in Bionano Genomics in Q1 2021 and held it in 10 quarters.
Kestra Advisory Services's Bionano Genomics position peaked at $122K in Q1 2021.
46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Kestra Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.